Externautics

company

About

Externautics is a biotech company exploiting possibilities for the identification and development of diagnostics for oncology applications.

  • 11 - 50

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$3.89M
Industries
Biotechnology
Founded date
Jan 1, 2007
Number Of Employee
11 - 50
Operating Status
Active

EXTERNAUTICS is an innovative biotech company established in 2007 to exploit the unique possibilities offered by the Reverse Proteomic YOMICS® Platform toward the identification and development of novel diagnostic and therapeutic markers for Oncology applications.

The past ten years have seen a tremendous increase in the use of Monoclonal Antibodies for the treatment of cancer diseases. Herceptin and Erbitux are clear examples of the present trends of the cancer clinical therapy to target and kill tumor cells on the basis of specific protein markers present on the tumors. Yet, the frequency of tumor regression is still limited to a very low percentage of the patient population submitted to treatment.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$3.89M
Externautics has raised a total of $3.89M in funding over 2 rounds. Their latest funding was raised on Jun 5, 2008 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 5, 2008 Series Unknown $3.89M 2 Detail

Investors

Number of Lead Investors
Number of Investors
2
Externautics is funded by 2 investors. Biofund and MPS Venture are the most recent investors.
Investor Name Lead Investor Funding Round
Biofund Series Unknown
MPS Venture Series Unknown